PoliticsBiogen gets European OK for biosimilar drug By Robert Weisman — Boston GlobeJan. 19, 2016 Reprints Biogen and its Korean partner received approval from the EC for a generic version of a rheumatoid arthritis drug. AP/Biogen Biogen gets European OK for rheumatoid arthritis drug About the Author Reprints Robert Weisman — Boston Globe [email protected] @GlobeRobW Tags arthritis Biogen policy regulations
Politics Helen Branswell, Rachel Cohrs and Damian Garde STAT Plus: 8 burning questions Bernie Sanders and other senators should ask Moderna’s Stéphane Bancel
Health Tech Brittany Trang and Casey Ross STAT Plus: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
Business Bob Herman and Casey Ross STAT Plus: Buyer’s remorse: How a Medicare Advantage business is strangling one of its first funders
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
